
This article is part of a six-part series focusing on the Wyeth-sponsored non-profit coalition Depression Is Real. To learn more about this series, please click here.
« June 2007 | Main | August 2007 »
Jul31
|
![]()
This article is part of a six-part series focusing on the Wyeth-sponsored non-profit coalition Depression Is Real. To learn more about this series, please click here.
|
Jul26
|
![]()
This article is part of a six-part series focusing on the Wyeth-sponsored non-profit coalition Depression Is Real. To learn more about this series, please click here....
Continue Reading
|
Jul24
|
![]()
This article is part of a six-part series focusing on the Wyeth-sponsored non-profit coalition Depression Is Real. To learn more about this series, please click here....
Continue Reading
|
Jul19
|
![]()
This month, Wyeth’s new birth control pill Lybrel will be hitting pharmacy shelves. The product, which was approved by the Food and Drug Administration (FDA) in May, is being touted as the first medication that will eliminate a woman’s monthly...
Continue Reading
|
Jul17
|
![]()
For those involved in health communications campaigns, it’s an common question: “Should I resort to scare tactics?” I’ve lost count of the number of times I’ve been in brainstorming sessions where I’ve argued with my colleagues about the merits of...
Continue Reading
|
Jul13
|
![]()
Last April, I received a very interesting e-mail from the public relations firm Porter Novelli. The agency was writing on behalf of a group of seven non-profit organizations who had joined together to help educate the public about depression. Each...
Continue Reading
|
Jul11
|
![]()
Over the past few days, I’ve been having a number of conversations about social media communications strategy with various executives within the healthcare industry. One of the points I’ve been making is that when we think about communicating with patients...
Continue Reading
|
Jul 3
|
![]()
This morning an interesting story appeared in the Wall Street Journal (subscription required) focusing on how databases and powerful software are enabling researchers to identify “signals” regarding the side effects of prescription medications. According to the article, Ralph Edwards, director...
Continue Reading
|